Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdullah Ely

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Expert Opinion on Therapeutic Targets|April 12, 2021
Hepatitis B virus: promising drug targets and therapeutic implicationsMohube Betty Maepa, Kristie Bloom, Abdullah Ely, et al.
Journal of Hepatocellular Carcinoma|February 5, 2021
Recent Update on the Role of Circular RNAs in Hepatocellular CarcinomaAbdullah Ely, Kristie Bloom, Mohube Betty Maepa, et al.
Future Microbiology|November 9, 2013
Recent advances in developing nucleic acid-based HBV therapyMusa Marimani, Justin Hean, Kristie Bloom, et al.
Biochemical and Biophysical Research Communications|July 6, 2010
tRNA Lys3 promoter cassettes that efficiently express RNAi-activating antihepatitis B virus short hairpin RNAsVictoria Dyer, Abdullah Ely, Kristie Bloom, et al.
Pharmaceutics|April 28, 2023
Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA VaccinesDylan Kairuz, Nazia Samudh, Abdullah Ely, et al.
Frontiers in Immunology|November 10, 2022
Advancing mRNA technologies for therapies and vaccines: An African contextDylan Kairuz, Nazia Samudh, Abdullah Ely, et al.
Frontiers in Immunology|February 14, 2022
Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular CarcinomaNazia Samudh, Creanne Shrilall, Patrick Arbuthnot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2013
Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleasesKristie Bloom, Abdullah Ely, Claudio Mussolino, et al.
Antiviral Therapy|December 4, 2013
Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettesCarol Crowther, Mohube B Mowa, Abdullah Ely, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2008
Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivoAbdullah Ely, Tanusha Naidoo, Steven Mufamadi, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Expert Opinion on Therapeutic Targets|April 12, 2021
Hepatitis B virus: promising drug targets and therapeutic implicationsMohube Betty Maepa, Kristie Bloom, Abdullah Ely, et al.
Journal of Hepatocellular Carcinoma|February 5, 2021
Recent Update on the Role of Circular RNAs in Hepatocellular CarcinomaAbdullah Ely, Kristie Bloom, Mohube Betty Maepa, et al.
Future Microbiology|November 9, 2013
Recent advances in developing nucleic acid-based HBV therapyMusa Marimani, Justin Hean, Kristie Bloom, et al.
Biochemical and Biophysical Research Communications|July 6, 2010
tRNA Lys3 promoter cassettes that efficiently express RNAi-activating antihepatitis B virus short hairpin RNAsVictoria Dyer, Abdullah Ely, Kristie Bloom, et al.
Pharmaceutics|April 28, 2023
Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA VaccinesDylan Kairuz, Nazia Samudh, Abdullah Ely, et al.
Frontiers in Immunology|November 10, 2022
Advancing mRNA technologies for therapies and vaccines: An African contextDylan Kairuz, Nazia Samudh, Abdullah Ely, et al.
Frontiers in Immunology|February 14, 2022
Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular CarcinomaNazia Samudh, Creanne Shrilall, Patrick Arbuthnot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2013
Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleasesKristie Bloom, Abdullah Ely, Claudio Mussolino, et al.
Antiviral Therapy|December 4, 2013
Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettesCarol Crowther, Mohube B Mowa, Abdullah Ely, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2008
Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivoAbdullah Ely, Tanusha Naidoo, Steven Mufamadi, et al.
Pageof 6